By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – WaferGen Biosystems today reported that its fourth-quarter revenues more than tripled on sales of its SmartChip products.

The Fremont, Calif.-based firm brought in total revenues of $712,369 for the three-month period ended Dec. 31, compared to $189,757 for the fourth quarter of 2009. The increase was driven by sales of its SmartChip Real-Time PCR System, which was launched in August 2010, and associated consumables and services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.